IMIDomics Collaborates with Gossamer Bio to Develop Therapies for Treating Immune-Mediated Inflammatory Diseases

 IMIDomics Collaborates with Gossamer Bio to Develop Therapies for Treating Immune-Mediated Inflammatory Diseases

IMIDomics Collaborates with Gossamer Bio to Develop Therapies for Treating Immune-Mediated Inflammatory Diseases

Shots:

  • The companies collaborates on multiple projects, being the first for inflammatory bowel disease(IBD) to develop and discover therapies for treating Immune-Mediated Inflammatory Diseases (IMIDs)
  • The focus of the collaboration will allow Gossamer’s immunology research and development team to utilize IMIDomics’ unique clinical and molecular patient database for product discovery and development strategy
  • IMIDomics’ platform has access to dynamic and high-quality IMID patient biobank, clinical data, proprietary multiomics molecular data and world-class clinical expertise

Click here to read full press release/ article | Ref: BioSpace | Image: Behance

Shiwani Sharma

Shiwani Sharma was Senior Editor at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post